SCHEMBL6900575

SCHEMBL6900575

CCOC(=O)c1ccc(Nc2ccccc2C)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.62
MEN1 O00255 7/20 0.62
KMT2A Q03164 7/20 0.62
RAB9A P51151 5/20 0.62
NPC1 O15118 5/20 0.62
ALDH1A1 P00352 4/20 0.62
GAA P10253 3/20 0.62
MAPT P10636 5/20 0.60
TP53 P04637 1/20 0.60
CDKN1A P38936 1/20 0.60
RXFP1 Q9HBX9 1/20 0.56
THRB P10828 2/20 0.56
SLC2A1 P11166 1/20 0.56
HPGD P15428 4/20 0.55
KDM4E B2RXH2 2/20 0.55
APAF1 O14727 1/20 0.55
MITF O75030 1/20 0.55
NR4A1 P22736 1/20 0.55
HTT P42858 1/20 0.55
SMAD3 P84022 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4778970 0.88 SMN1; SMN2 (0.71) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL4780884 0.86 MAPT (0.70) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL2255472 0.85 MAPK13 (0.60) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL3627660 0.84 MAPT (0.62) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL9176722 0.84 SMN1; SMN2 (0.72) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL4778966 0.84 CDC25B (0.52) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL12124929 0.84 RAB9A (0.69) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL16453466 0.83 MEN1 (0.58) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL19245018 0.82 CDC25B (0.57) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL2258175 0.81 ALDH1A1 (0.68) SMN1; SMN2MEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013787-B1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES COUNCIL SCIENT IND RES (IN) 2017-08-02 EP disclosed
EP-3013787-A1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES Council of Scientific & Industrial Research (IN) 2016-05-04 EP disclosed
WO-2014207761-A1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-12-31 WO disclosed
EP-1100485-A4 SUBSTITUTED ANILIDE COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-06-09 EP disclosed
EP-1100485-A1 SUBSTITUTED ANILIDE COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2001-05-23 EP disclosed
WO-2000006146-A9 SUBSTITUTED ANILIDE COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2000-08-03 WO disclosed
WO-2000006146-A1 SUBSTITUTED ANILIDE COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed
US-5854236-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1998-12-29 US disclosed
WO-1997047625-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1997-12-18 WO disclosed
WO-1997047624-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1997-12-18 WO disclosed